CXCL5

From WikiMD's WELLNESSPEDIA

CXCL5 is a small cytokine belonging to the CXC chemokine family that is also known as epithelial-derived neutrophil-activating peptide 78 (ENA-78). It is produced following stimulation of cells such as epithelial cells, platelets, and monocytes with the inflammatory cytokines interleukin-1 or tumor necrosis factor-alpha. Expression of this gene is also induced by epidermal growth factor.

Function[edit]

CXCL5 is a chemotactic agent for neutrophil granulocytes. It attracts these cells by interacting with the cell surface chemokine receptor CXCR2. Its gene is located in a cluster of other chemokines on chromosome 4q13.3 in humans.

Clinical significance[edit]

CXCL5 has been implicated in various inflammatory and cancer-related conditions. It is associated with inflammatory diseases such as rheumatoid arthritis, lung fibrosis, and atherosclerosis. In cancer, it has been shown to promote angiogenesis, tumor growth, and metastasis.

See also[edit]

References[edit]


External links[edit]






Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.